194 articles – 65 Notices  [english version]
.:. Consultation > Par année > 2003 .:.
4 documents classés par :
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.
Oger E., Alhenc-Gelas M., Lacut K., Blouch M.-T., Roudaut N., Kerlan V., Collet M., Abgrall J.-F., Aiach M., Scarabin P.-Y. et al
Arteriosclerosis, Thrombosis, and Vascular Biology 23, 9 (2003) 1671-6 [hal-00722263 - version 1]
Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein.
Lacut K., Oger E., Le Gal G., Blouch M.-T., Abgrall J.-F., Kerlan V., Scarabin P.-Y., Mottier D.
Thrombosis and Haemostasis 90, 1 (2003) 124-31 [hal-00722269 - version 1]
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.
Oger E., Lacut K., Van Dreden P., Bressollette L., Abgrall J.-F., Blouch M.-T., Scarabin P.-Y., Mottier D.
Haematologica -Pavia then Roma- 88, 4 (2003) 465-9 [hal-00722260 - version 1]
Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study.
Le Gal G., Gourlet V., Hogrel P., Plu-Bureau G., Touboul P.-J., Scarabin P.-Y.
Atherosclerosis 166, 1 (2003) 163-70 [hal-00722267 - version 1]